Skip To The Main Content

Deep Dive into Biosimilars Continues


2018 PDA Biosimilars Workshop Outlines Global Regulators’ Expectations

The 2018 PDA Biosimilars Workshop held in Washington, D.C. last September provided an opportunity for further discussion on the topic of biosimilars, enabling industry representatives, academics and global regulators to convene around an increasingly critical topic.